BREAKING NEWS: new data suggests Pfizer/BioNTech’s COVID-19 vaccine is 95% effective
Companies to submit vaccine for emergency authorisation in the US ‘within days’
Read More
Tag: BNT162b2
BREAKING NEWS: early data indicates Pfizer/BioNTech’s COVID-19 vaccine is 90% effective
Phase III study of vaccine candidate involved 43,538 participants
Read More
Pfizer and BioNTech select lead mRNA vaccine against COVID-19
The companies have started a global pivotal Phase II/III safety and efficacy study
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
